URL has been copied successfully!
Pharmaceutical companies are hungry to make deals, and they’re making more than they have in years.
In the past six months, there have been 32 biotech acquisitions valued at $1 billion or more. Pharmaceutical companies and even some large biotech companies have spent around $123 billion on these deals.
They’ve blown past last year’s totals in roughly half the amount of time. Pharma companies struck 26 blockbuster M&A deals in 2025, spending $112 billion altogether.
Please follow us:
